Terms: = Lymphoma AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
484 results:
1. A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in Female Rats.
Hata T; Uematsu Y; Sugita A; Adachi H; Kato S; Hirate M; Ishikura KI; Kaku A; Ohara H; Kojima N; Takahashi T; Kurokawa T
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38500360
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
Bodakçi E
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent remission of lymphoma and Sjögren's disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a case report.
Sheng L; Zhang Y; Song Q; Jiang X; Cao W; Li L; Yi H; Weng X; Chen S; Wang Z; Wu W; Wang L; Zhao W; Yan Z
Front Immunol; 2023; 14():1298815. PubMed ID: 38173731
[TBL] [Abstract] [Full Text] [Related]
4. A rare case of cutaneous lupus erythematosus presenting with periorbital erythema and edema.
Hacınecipoğlu F; Çevirgen Cemil B; Kartal SP; Arslankoz S
Lupus; 2024 Feb; 33(2):183-186. PubMed ID: 38148123
[TBL] [Abstract] [Full Text] [Related]
5. EBF1, MYO6 and calr expression levels predict therapeutic response in diffuse large B-cell lymphomas.
Turdo A; Gaggianesi M; D'Accardo C; Porcelli G; Bella SD; Cricchio D; Pillitteri I; Porcasi R; Lo Iacono M; Verona F; Modica C; Roozafzay N; Florena AM; Stassi G; Mancuso S; Todaro M
Front Immunol; 2023; 14():1266265. PubMed ID: 38035116
[TBL] [Abstract] [Full Text] [Related]
6. Mycosis fungoides with spongiosis: a case report.
Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
[TBL] [Abstract] [Full Text] [Related]
7. AMPK activation induces immunogenic cell death in AML.
Mondesir J; Ghisi M; Poillet L; Bossong RA; Kepp O; Kroemer G; Sarry JE; Tamburini J; Lane AA
Blood Adv; 2023 Dec; 7(24):7585-7596. PubMed ID: 37903311
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights.
Tang IYK; Ho CTK; Li TWL; Li PH
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902361
[TBL] [Abstract] [Full Text] [Related]
9. [Salivary gland ultrasound or biopsy? : Comparison of methods based on case examples].
Peters J; Timme-Bronsert S; Voll RE; Finzel S
Z Rheumatol; 2023 Oct; 82(8):654-665. PubMed ID: 37782326
[TBL] [Abstract] [Full Text] [Related]
10. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
[TBL] [Abstract] [Full Text] [Related]
11. Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?
Baldini C; Berardicurti O; Giacomelli R; Bombardieri M
Autoimmun Rev; 2024 Jan; 23(1):103425. PubMed ID: 37634677
[TBL] [Abstract] [Full Text] [Related]
12. Significant heterogeneity in management of calreticulin-mutated essential thrombocythemia and its progression to myelofibrosis: results of a national survey.
Murton A; Forsyth C; Ross DM; Grigg A
Leuk Lymphoma; 2023 Dec; 64(12):2018-2025. PubMed ID: 37574855
[TBL] [Abstract] [Full Text] [Related]
13. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.
Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
[TBL] [Abstract] [Full Text] [Related]
14. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
15. Orelabrutinib versus ibrutinib for patients with refractory/relapsed primary central nervous system lymphoma: An efficacy and safety analysis.
Qiao L; Liu Q; Huang C
Medicine (Baltimore); 2023 Jul; 102(27):e33880. PubMed ID: 37417642
[TBL] [Abstract] [Full Text] [Related]
16. Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort.
Mezger NCS; Hämmerl L; Griesel M; Seraphin TP; Joko-Fru YW; Feuchtner J; Zietsman A; Péko JF; Tadesse F; Buziba NG; Wabinga H; Nyanchama M; Chokunonga E; Kéita M; N'da G; Lorenzoni CF; Akele-Akpo MT; Mezger JM; Binder M; Liu B; Bauer M; Henke O; Jemal A; Kantelhardt EJ
Oncologist; 2023 Nov; 28(11):e1017-e1030. PubMed ID: 37368350
[TBL] [Abstract] [Full Text] [Related]
17.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
[TBL] [Abstract] [Full Text] [Related]
19. Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer.
Chen Y; Sun J; Dong X; Sun D; Qu Y
World J Surg Oncol; 2023 Jun; 21(1):174. PubMed ID: 37287039
[TBL] [Abstract] [Full Text] [Related]
20. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.
Oh BC; Cho AR; Nam JH; Yang SY; Kim MJ; Kwon SH; Lee EK
BMC Cancer; 2023 May; 23(1):482. PubMed ID: 37248452
[TBL] [Abstract] [Full Text] [Related]
[Next]